TABLE 7.
Units Injected, Unavoidable Wastage, Billable Units, and Reimbursement Cost for Unavoidable Wastagea
|
ONA
n = 141 |
ABO
n = 141 |
P Value | |
|---|---|---|---|
| Total toxin units injected, mean (SD) | 284 (62) | 552 (120) | — |
| Unavoidable toxin units wasted across cycles, mean (SD) | 36 (12) | 82 (44) | < 0.0001 |
| Total toxin units billed, mean (SD) | 320 (68) | 634 (137) | — |
| Total toxin reimbursement, median (range) $ | 1,710 (0-2,660) | 988 (0-2,747) | — |
| Total reimbursement for unavoidable toxin waste per cycle,b median (range) $ | 165 (0-435) | 148 (0-550) | < 0.0001 |
a n = injection cycles.
b Excludes cost of wastage for BoNT administered as samples (ONA = 7 cycles, ABO = 4 cycles), since no reimbursement for this wastage was incurred.
ABO = abobotulinumtoxinA; BoNT = botulinum neurotoxin; ONA = onabotulinumtoxinA; SD = standard deviation.